It has the potential to rewrite a great deal of what we think we know ... The social environment, then, is genetics one degree removed. And vice versa. When scientists started decoding the human ...

A simple genomics blood test could improve treatment and care for childhood epilepsy, but more investment is needed to make access fair and securely join up the data, finds a new study involving ...

Highlights,Institutional investors adjusted their holdings in Myriad Genetics.,The company reported revenue growth in the latest quarter.,Myriad Genetics specializes in molecular diagnostic ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler analysts upgraded the stock's rating from Neutral to Buy. The ...

Unfortunately, Myriad Genetics struggled to consistently increase demand as its $837.6 million of sales for the trailing 12 months was close to its revenue five years ago. This wasn’t a great ...